No definition available.
Osteosarcoma, excluding all cancers (controls excluding all cancers)
C3_OSTEOSARCOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
136 |
4. Check minimum number of eventsNone |
136 |
5. Include endpointsNone |
136 |
6. Filter based on genotype QC (FinnGen only) |
136 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Osteosarcoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 136 | 62 | 74 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 33.83 | 29.65 | 37.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 71
- Matched controls
- 711
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
52.8
44
*
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
51.4
43
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
41.8
36
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
120.0
32.3
33
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
272.7
20.7
20
*
L03AA02
ATC
filgrastim; parenteral
254.2
19.6
19
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
127.0
18.6
19
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
18.5
17
*
N02AA05
ATC
oxycodone; systemic
16.7
17.4
29
28
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
16.2
15
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
15.1
14
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.1
14
*
NF3AA
NOMESCO Finland
Femur X-ray examination
67.5
14.5
16
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.6
14.2
46
138
ZXE20
NOMESCO Finland
More than three and less than five hours
13.1
13.7
25
28
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
12.9
12
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
27.3
12.7
17
8
NG4AA
NOMESCO Finland
Lower leg X-ray examination
27.3
12.7
17
8
A04AA01
ATC
ondansetron; systemic, rectal
33.7
12.7
16
6
JN4BD
NOMESCO Finland
Extensive body CT
18.0
12.3
19
14
WX408
NOMESCO Finland
General anesthesy, balanced
6.8
12.2
38
102
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.8
11
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
11.8
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
31.0
11.7
15
6
N03AX16
ATC
pregabalin; oral
7.3
11.4
31
68
GD1AD
NOMESCO Finland
Thorax CT examination
34.2
11.2
14
5
A03FA01
ATC
metoclopramide; systemic, rectal
8.4
10.7
25
43
TPX15
NOMESCO Finland
Removal of vascular injection port
+∞
10.7
10
*
B01AB05
ATC
enoxaparin; parenteral
6.4
10.6
33
85
ZXA05
NOMESCO Finland
Left side
6.3
10.4
32
81
ZXE10
NOMESCO Finland
More than one and less than three hours
5.6
10.3
39
127
H02AB02
ATC
dexamethasone; systemic
64.0
9.9
11
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.6
9.8
22
35
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
114.5
9.7
10
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
9.6
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.6
9
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
9.6
9
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
9.6
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.6
9
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
18.9
9.5
14
9
R4110
NOMESCO Finland
Physiotherapy
5.7
9.4
31
84
WX302
NOMESCO Finland
Thoracal epidural anesthesy
42.6
9.3
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
5.0
9.2
39
139
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.2
9.1
15
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.8
8.9
38
136
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.6
8.8
18
24
WW500
NOMESCO Finland
Blood transfusion
31.9
8.8
11
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
8.0
8.7
20
33
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
101.5
8.6
9
*
Z51.5
ICD-10 Finland
Palliative care
101.5
8.6
9
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
8.5
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.5
8
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
8.5
8
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
8.5
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.5
8
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
8.5
8
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.8
8.4
26
64
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
25.5
8.3
11
5
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
25.5
8.3
11
5
N02AX02
ATC
tramadol; systemic, rectal
4.5
8.1
38
144
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
9.5
7.9
16
21
ZXE00
NOMESCO Finland
One hour or less
4.2
7.7
42
181
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.1
7.5
26
72
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
7.4
7
*
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
+∞
7.4
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
9.9
7.2
14
17
ZXA00
NOMESCO Finland
Right side
4.4
6.7
27
86
WX306
NOMESCO Finland
Lumbar epidural anesthesy
7.6
6.6
15
24
9101
FHL
Bone biopsy
76.3
6.5
7
*
NFQ20
NOMESCO Finland
Amputation of femur
76.3
6.5
7
*
WX402
NOMESCO Finland
General anaesthesia
5.2
6.5
21
53
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
20.2
6.4
9
5
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
20.2
6.4
9
5
ZXE40
NOMESCO Finland
More than seven and less than nine hours
29.5
6.4
8
*
JN4CD
NOMESCO Finland
Very extensive body CT
29.5
6.4
8
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
+∞
6.3
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
B01AB10
ATC
tinzaparin; parenteral
14.3
6.3
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
31
30
13.09
29.12
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
82
314
5.06
19.75
3.9
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
17
0
+∞
18.12
32.5
0.0
umol/l
0.4
—
—
17
0
(3044640) Blood type and Crossmatch panel - Blood
69
258
4.40
16.49
5.9
2.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
81
344
4.35
16.16
10.1
4.5
g/l
35.0
36.5
1.54
76
325
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
27
47
6.92
15.62
15.9
7.5
%
0.9
0.7
0.80
27
47
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
193
4.36
15.41
7.0
1.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
27
48
6.77
15.30
15.8
7.4
%
1.3
1.6
0.61
27
48
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
86
397
4.17
14.90
24.2
6.2
mmol/l
1.2
1.2
0.67
80
364
(3002256) Pathology report gross observation
34
82
5.20
13.93
1.5
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
89
435
4.03
13.88
26.5
6.6
mmol/l
1.2
1.2
0.42
75
389
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
12
12.89
13.74
2.1
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
59
220
3.97
13.70
8.1
3.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
35
89
4.95
13.45
13.1
6.4
kpa
14.0
12.0
1.17
35
84
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
35
89
4.95
13.45
13.1
6.4
kpa
5.4
5.1
1.10
35
84
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
131
4.19
12.37
2.4
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
15
10.29
11.86
1.6
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
15
10.29
11.86
1.6
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
73
349
3.36
11.05
10.2
7.4
inr
1.1
1.2
0.67
21
90
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
23
7.75
10.82
14.8
2.6
u/ml
0.2
0.3
—
9
16
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
80
411
3.30
10.61
7.4
3.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
27
67
4.78
10.55
47.4
10.3
mmol/l
25.3
24.5
0.70
27
67
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
20
38
6.00
10.47
3.6
1.7
ug/l
28.7
2.9
0.48
15
26
(3042936) Bacteria identified in Isolate by Culture
40
137
3.72
10.15
2.7
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
26
65
4.71
10.04
2.9
3.4
g/l
0.2
0.2
0.08
26
60
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
95
4.10
9.92
2.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
67
329
3.04
9.30
17.5
6.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
35
5.77
9.17
14.6
9.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
95
3.93
9.16
2.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
55
247
3.06
8.87
8.5
3.2
ph
7.4
7.4
0.52
14
33
(3013650) Neutrophils [#/volume] in Blood by Automated count
96
586
3.17
8.84
30.9
7.5
e9/l
3.9
4.2
0.86
86
504
(3007853) Bacteria identified in Skin by Aerobe culture
34
115
3.61
8.69
2.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
68
4.07
7.84
5.4
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
9
14.47
7.54
1.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
22
6.43
7.53
1.8
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
7
15.28
6.50
1.3
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
83
522
2.51
6.33
13.5
6.0
e9/l
0.5
0.6
0.84
75
448
(3006315) Basophils [#/volume] in Blood
83
522
2.51
6.33
13.5
6.0
e9/l
0.0
0.0
1.32
76
446
(40758558) Short blood count panel - Blood
51
256
2.59
6.31
25.2
6.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
84
535
2.49
6.18
13.4
6.1
e9/l
1.5
1.9
4.60
79
471
(3022948) Iron [Moles/volume] in Serum or Plasma
32
130
2.91
5.92
3.4
2.8
umol/l
13.5
14.5
0.28
32
117
(3019060) Gas panel - Arterial blood
18
51
3.92
5.83
4.5
5.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
72
3.45
5.80
2.8
1.8
ml/min/173m2
89.6
72.2
0.94
12
27
(3013115) Eosinophils [#/volume] in Blood
83
537
2.40
5.74
17.6
6.6
e9/l
0.2
0.2
2.22
77
472
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
25
5.17
5.61
1.8
2.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
60
341
2.36
5.54
4.1
3.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
25
94
3.03
5.27
29.6
7.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
13
31
4.53
5.22
6.7
3.2
%
215.2
173.7
0.97
13
31
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
84
3.09
5.08
43.1
4.9
mmol/l
1.1
1.5
1.77
23
78
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
42
3.89
4.92
2.1
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
10
9.54
4.86
1.1
1.0
—
—
—
0
0
(44806118)
8
7
12.04
4.85
1.8
1.3
—
—
—
0
0
(44790047)
8
7
12.04
4.85
1.8
1.3
—
—
—
0
0
(44790049)
8
7
12.04
4.85
1.8
1.3
—
—
—
0
0
(44790048)
8
7
12.04
4.85
1.8
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
49
274
2.23
4.54
3.1
3.5
e6/l
0.4
0.3
0.08
36
195
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
55
3.39
4.54
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
12
7.94
4.43
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
52
303
2.16
4.32
3.3
3.4
e6/l
49.8
281.9
0.53
41
224
(36304419) Bacteria [Presence] in Urine
47
265
2.18
4.23
3.2
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
38
197
2.29
4.18
2.9
3.0
e6/l
9.2
4.6
0.71
38
169
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
10
8.41
4.12
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
7
10.45
4.06
2.4
3.9
—
—
—
0
0
(3036489) Thrombin time
14
43
3.51
4.03
9.1
2.4
s
21.0
20.6
0.20
14
38
(3037121) Protein [Mass/volume] in Urine
12
33
3.89
4.02
6.0
5.8
g/l
0.2
0.2
—
7
15
(3003694) ABO and Rh group [Type] in Blood
46
267
2.09
3.79
1.7
1.5
—
—
—
0
0
(3020891) Body temperature
13
40
3.49
3.73
11.0
4.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
12
7.00
3.73
1.4
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
13
6.46
3.55
6.3
5.0
kpa
5.2
4.9
—
8
13
(3027315) Oxygen [Partial pressure] in Blood
8
13
6.46
3.55
6.3
5.0
kpa
7.3
8.1
—
8
13
(3002179) Metamyelocytes/100 leukocytes in Blood
17
64
2.89
3.55
3.1
4.3
%
0.7
0.5
—
12
10
(3026782) Osmolality of Urine
34
182
2.16
3.41
3.0
3.0
mosm/kgh2o
576.4
574.2
0.02
34
143
(3024928) Oxygen saturation in Venous blood
9
19
4.99
3.30
61.0
2.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
15
5.59
3.24
70.4
2.4
%
55.8
67.0
—
8
15
(3044889) 12 lead EKG panel
88
666
1.91
3.19
4.3
3.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
8
7.78
3.08
8.5
3.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
5
10.31
3.00
1.4
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
5
10.31
3.00
2.4
5.8
%
98.6
107.2
—
5
5
(3011648) Oxygen content in Venous blood
5
5
10.31
3.00
108.6
2.6
%
8.8
11.4
—
5
5
(3022313) Gas panel - Capillary blood
15
58
2.78
2.99
8.0
8.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
9
6.91
2.90
1.2
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
17
72
2.56
2.86
3.4
4.1
%
1.8
0.9
0.84
12
16
(3021589) Normoblasts [#/volume] in Blood
65
459
1.80
2.83
28.0
7.6
e9/l
0.0
0.0
0.00
54
363
(3018095) Leukocytes [#/volume] in Urine
53
355
1.81
2.73
4.4
3.9
e6/l
29.9
88.1
1.05
42
237
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
109
2.21
2.64
13.1
7.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
56
386
1.77
2.60
2.9
2.7
nmol/l
74.1
75.1
0.10
50
339
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
11
5.65
2.57
1.0
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
11
5.65
2.57
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
7
7.36
2.57
9.8
4.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
7
7.36
2.57
2.2
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
76
2.41
2.56
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
83
2.35
2.54
7.3
6.9
kpa
5.2
4.9
1.22
18
72
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
353
1.77
2.53
4.3
3.5
ng/l
15.0
40.7
1.89
39
224
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
212
1.88
2.45
7.2
1.9
mg/l
2.1
1.3
0.58
30
160
(3019225) pH of Specimen
17
78
2.35
2.43
13.2
3.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
8
6.43
2.39
1.2
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
8
6.43
2.39
1.2
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
13
4.77
2.29
1.7
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
9
5.72
2.23
1.2
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
96
790
1.73
2.21
4.6
3.5
pmol/l
15.1
14.7
0.76
88
721
(1616796) Gas panel - Central venous blood
6
14
4.43
2.17
3.0
5.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
10
5.14
2.09
1.6
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.14
2.09
1.6
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.14
2.09
1.6
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
10
5.14
2.09
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
77
2.22
2.06
8.0
7.3
mmol/l
1.4
1.0
0.13
16
55
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
15
4.13
2.06
3.8
3.1
%
56.7
55.2
—
6
15
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
15
4.13
2.06
1.5
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
15
4.13
2.06
3.0
3.1
e9/l
3.9
4.1
—
6
15
(40761535) Cells panel - Urine sediment
17
84
2.17
2.06
5.0
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
123
1101
2.23
2.05
35.3
10.4
mg/l
30.5
22.1
1.71
109
813
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
26
3.20
2.05
1.4
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
21
3.46
1.99
4.4
3.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
45
2.57
1.98
57.3
2.8
%
1.3
1.1
0.43
11
45
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
27
3.08
1.97
2.0
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
11
4.67
1.96
2.2
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
110
955
1.79
1.93
26.6
8.7
ml/min/173m2
91.4
87.5
0.86
99
754
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.64
1.86
1.7
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.64
1.86
1.7
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
126
1150
2.30
1.80
40.5
11.5
umol/l
78.6
76.2
0.17
126
1150
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
64
2.14
1.60
2.2
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
20
3.09
1.60
2.7
2.5
—
—
—
0
0
(3012544) pH of Venous blood
20
116
1.85
1.59
50.9
4.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
140
1.77
1.58
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
44
0.00
1.54
0.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
21
2.94
1.52
1.7
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
14
73
2.02
1.50
6.7
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
83
694
1.50
1.49
5.9
4.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
22
2.80
1.45
1.5
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
16
3.20
1.45
1.2
1.4
nmol/l
0.1
0.8
—
5
11
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
205
0.50
1.43
1.7
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
23
2.68
1.38
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
23
2.68
1.38
2.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
188
0.49
1.33
1.8
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
117
0.41
1.32
1.6
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
92
1.84
1.32
3.2
2.4
nmol/l
328.3
351.1
0.25
16
85
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
25
2.46
1.26
2.0
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
26
2.37
1.20
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
124
1157
1.81
1.15
27.5
9.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
31
2.32
1.12
1.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
28
198
1.52
1.09
3.7
3.2
ng/l
39.9
205.9
1.96
23
142
(3004588) Protein electrophoresis panel - Serum or Plasma
10
52
2.00
1.09
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
35
261
1.46
1.06
2.6
3.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
22
2.32
1.04
1.8
1.5
u/ml
185.2
141.5
—
5
10
(3022145) Colonoscopy Study observation
14
84
1.74
1.02
1.5
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
176
1.52
1.00
2.8
2.9
e6/l
0.9
1.1
0.20
12
103
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
10
54
1.92
0.99
6.0
3.4
pmol/l
5.0
5.1
—
10
47
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
107
975
1.46
0.99
5.2
4.1
mu/l
2.1
1.8
1.09
100
895
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
28
0.00
0.99
0.0
1.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
9
50
1.86
0.99
11.0
8.5
kpa
9.1
9.7
—
9
43
(3009508) Creatinine [Moles/volume] in Urine
42
330
1.39
0.96
3.4
3.3
mmol/l
6.9
8.1
0.86
35
290
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
44
354
1.36
0.87
1.7
1.8
pmol/l
96.4
92.4
0.17
22
187
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
166
1.46
0.82
3.0
2.9
e6/l
3.4
2.8
—
9
93
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
25
0.00
0.80
0.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
96
1038
0.74
0.78
4.4
3.9
mmol/l
1.4
1.4
0.18
90
969
(3015736) pH of Urine
47
388
1.32
0.77
4.5
3.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
23
2.22
0.77
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
31
241
1.37
0.75
6.1
4.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
145
0.59
0.74
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
198
1.39
0.71
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
92
995
0.77
0.69
4.2
3.6
mmol/l
1.2
1.3
0.21
86
928
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
99
1060
0.76
0.68
4.4
4.3
mmol/l
2.8
2.8
0.21
93
994
(3025941) Bacteria identified in Stool by Culture
10
62
1.66
0.67
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
28
1.81
0.67
1.4
2.4
mmol/l
26.7
22.8
—
5
20
(3007566) Smooth muscle Ab [Titer] in Serum
5
28
1.81
0.67
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
28
1.81
0.67
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
237
1.34
0.66
5.2
3.8
—
—
—
0
0
(3013512) EKG study
29
228
1.35
0.66
5.4
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
57
494
1.26
0.63
5.9
3.5
estimate
0.0
0.0
0.00
12
85
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
98
1047
0.77
0.63
4.4
4.0
mmol/l
4.6
4.6
0.05
92
984
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
30
1.69
0.62
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
22
0.00
0.60
0.0
1.0
—
1.9
—
0
9
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
87
940
0.79
0.59
5.7
5.2
mmol/mol
38.3
39.4
0.53
81
890
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
23
0.00
0.59
0.0
4.7
—
4.0
—
0
18
(42529406) Shigella sp [Presence] in Stool by Culture
6
36
1.70
0.57
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
36
1.70
0.57
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
36
1.70
0.57
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
386
0.78
0.57
2.7
2.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
110
1048
1.26
0.44
44.9
11.4
%
37.5
41.0
6.75
79
821
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
161
0.72
0.44
1.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
94
0.62
0.44
1.3
1.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
31
1.64
0.43
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
55
493
1.19
0.42
7.5
4.9
estimate
0.0
0.0
0.00
12
80
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.5
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
7.7
—
0
9
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
20
161
1.28
0.40
1.4
1.7
pmol/l
385.5
440.6
0.53
14
143
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
36
1.40
0.38
1.4
1.6
g/l
0.2
0.2
—
5
36
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5
80
0.61
0.36
1.2
1.2
—
192.6
—
0
28
(3029937) Albumin [Presence] in Urine by Test strip
31
268
1.20
0.34
7.5
3.7
estimate
0.0
0.0
0.00
12
82
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
250
1.20
0.33
1.3
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
78
828
0.86
0.32
3.7
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
123
1.25
0.26
1.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
81
0.73
0.25
2.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
82
0.72
0.25
2.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
83
0.71
0.25
3.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
83
0.71
0.25
2.2
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
54
503
1.12
0.23
6.0
3.5
estimate
0.0
0.0
0.00
12
81
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
48
1.26
0.20
1.8
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
48
1.26
0.20
2.0
2.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
143
0.82
0.19
1.7
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
253
1.13
0.19
1.8
1.4
g/l
2.3
2.1
0.26
18
151
(3022621) pH of Urine by Test strip
5
68
0.73
0.17
9.0
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
75
0.79
0.16
1.3
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
79
0.75
0.16
2.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
41
383
1.10
0.16
6.6
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
80
0.74
0.16
1.3
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
9
81
1.12
0.15
2.0
3.1
ug/l
3.2
6.3
—
9
70
(3012516) Albumin [Mass/volume] in Urine
29
267
1.11
0.14
3.1
3.2
mg/l
57.1
66.2
0.12
19
184
(40768797) Stomach Pathology biopsy report
14
122
1.16
0.14
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
12
104
1.17
0.13
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
279
1.10
0.12
3.5
3.8
mg/mmol
4.5
9.2
0.82
19
187
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
26
280
0.91
0.11
1.1
1.5
u/ml
2.1
2.2
—
6
67
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
63
0.79
0.08
2.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
26
276
0.93
0.08
2.7
3.5
%
27.1
23.3
0.66
15
128
(4010399)
7
65
1.08
0.08
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
67
1.05
0.08
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
147
1.10
0.07
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
110
0.90
0.05
1.8
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
108
0.92
0.03
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
273
1.03
0.01
5.8
2.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
99
996
0.98
0.00
4.1
3.9
mmol/l
5.6
5.8
1.01
91
916
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
262
0.99
0.00
1.5
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
195
0.97
0.00
1.8
2.5
ug/l
0.7
0.8
0.13
14
117
(44813793)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
1.5
—
0
6
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.1
—
0
7
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
65
0.92
0.00
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
6.6
—
0
7
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
216.8
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
17.8
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
91.6
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OSTEOSARCOMA_EXALLC – Osteosarcoma, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).